Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,004 | 238 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $830.78 | 46 | $0 (2024) |
| ABBVIE INC. | $517.08 | 41 | $0 (2024) |
| Lilly USA, LLC | $356.33 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $230.98 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $172.20 | 10 | $0 (2024) |
| PFIZER INC. | $166.16 | 11 | $0 (2024) |
| Abbott Laboratories | $152.24 | 9 | $0 (2024) |
| Amgen Inc. | $137.96 | 8 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $106.73 | 5 | $0 (2024) |
| Lundbeck LLC | $106.68 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,326 | 74 | Novo Nordisk Inc ($369.85) |
| 2023 | $1,045 | 64 | Novo Nordisk Inc ($237.80) |
| 2022 | $939.07 | 59 | ABBVIE INC. ($204.35) |
| 2021 | $694.79 | 41 | PFIZER INC. ($77.24) |
All Payment Transactions
238 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $26.42 | General |
| 12/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Obesity | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.28 | General |
| 08/28/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Neurology | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 780 | 1,033 | $121,116 | $39,791 |
| 2022 | 13 | 926 | 1,178 | $133,962 | $44,273 |
| 2021 | 12 | 887 | 1,207 | $137,329 | $50,280 |
| 2020 | 13 | 584 | 670 | $90,990 | $34,433 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 215 | $51,530 | $12,754 | 24.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 87 | 87 | $21,228 | $9,335 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 189 | $32,130 | $8,897 | 27.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 32 | 32 | $3,838 | $2,285 | 59.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 158 | 265 | $2,505 | $2,095 | 83.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 17 | 18 | $2,502 | $1,114 | 44.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $1,287 | $994.95 | 77.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 20 | 20 | $1,560 | $811.00 | 52.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 21 | 42 | $1,260 | $654.22 | 51.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 43 | 47 | $2,162 | $367.72 | 17.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 14 | 14 | $364.00 | $226.80 | 62.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 36 | 37 | $580.00 | $180.43 | 31.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 25 | 34 | $170.00 | $74.80 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 170 | 237 | $56,880 | $14,659 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 106 | 106 | $24,088 | $11,620 | 48.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 184 | 222 | $37,740 | $11,461 | 30.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 39 | 39 | $4,641 | $2,673 | 57.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 43 | 43 | $1,677 | $1,262 | 75.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 209 | 318 | $1,590 | $920.69 | 57.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 13 | $1,365 | $458.96 | 33.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 14 | 14 | $1,946 | $424.48 | 21.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 41 | 48 | $2,208 | $376.20 | 17.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 33 | 35 | $433.57 | $151.35 | 34.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $768.00 | $144.15 | 18.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 46 | 49 | $245.00 | $106.76 | 43.6% |
About Susan Weeks, NP
Susan Weeks, NP is a Family healthcare provider based in Martinsville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801868617.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Susan Weeks, NP has received a total of $4,004 in payments from pharmaceutical and medical device companies, with $1,326 received in 2024. These payments were reported across 238 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,004).
As a Medicare-enrolled provider, Weeks has provided services to 3,177 Medicare beneficiaries, totaling 4,088 services with total Medicare billing of $168,778. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Martinsville, VA
- Active Since 02/06/2006
- Last Updated 05/12/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1801868617
Products in Payments
- Ozempic (Drug) $372.88
- UBRELVY (Drug) $213.74
- Wegovy (Drug) $187.06
- VRAYLAR (Drug) $178.35
- MOUNJARO (Drug) $172.64
- NURTEC ODT (Drug) $143.29
- Rybelsus (Drug) $139.85
- QULIPTA (Drug) $124.99
- ELIQUIS (Drug) $123.10
- REXULTI (Drug) $106.73
- VYEPTI (Biological) $106.68
- TRINTELLIX (Drug) $100.83
- FREESTYLE LIBRE 3 (Device) $97.50
- JARDIANCE (Drug) $97.13
- AIRSUPRA (Drug) $94.10
- TRELEGY ELLIPTA (Drug) $92.97
- FARXIGA (Drug) $78.20
- QUVIVIQ (Drug) $70.33
- SPRAVATO (Drug) $70.24
- XIFAXAN (Drug) $67.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Martinsville
Wendy Gilraine
Family — Payments: $7,377
Ronikka Hannans, Fnp, FNP
Family — Payments: $5,218
Brandi Fritsche, Fnp, FNP
Family — Payments: $4,593
Ms. Melinda Winikur, Fnp, FNP
Family — Payments: $3,954
Mrs. Amanda Hundley, Crnp, CRNP
Family — Payments: $3,606
Mrs. Lyndsey Mcalexander, Fnp-C, FNP-C
Family — Payments: $3,436